论文部分内容阅读
本文分析了用天津生物化学制药厂生产的干扰素诱导物—聚肌胞注射液(Injecti polyI:C)治疗72例乙型病毒型肝炎的临床疗效,治疗组与对照组患者均符合1978年全国肝炎会议拟定的标准,两组均有50例
This article analyzes the clinical efficacy of 72 cases of hepatitis B virus infection treated with the Injecti polyI: interferon inducer produced by Tianjin Biochemical Pharmaceutical Factory. The patients in the treatment group and the control group all met the requirements of 1978 The proposed standard for hepatitis meeting was 50 in both groups